Search Results
Key lung cancer updates: KRAS(G12C) inhibitors and ADCs
KRAS G12C Inhibition in Advanced NSCLC: MRTX849
KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies
Dr. Parikh on KRAS Inhibitors in Lung Cancer
KRAS-mutant NSCLC: CodeBreak 100 trial of sotorasib
Unmet needs in KRAS-driven non-small cell lung cancer
ASCO 2022: Highlights in lung cancer
CodeBreak 100: sotorasib in KRAS-mutated NSCLC
Lung Cancer Webinar Series on The Treatment of KRAS
Dr. Fakih on the Safety Profile of AMG 510 in KRAS G12C-Mutated CRC
Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies
2021 West Oncology APP | Lung Cancer Treatments Update
